SUBSCRIBE
SUBSCRIBE
News   Business

Oxygen Biotherapeutics, Inc. Names New Chief Financial Officer

September 25, 2008 | 
1 min read
COSTA MESA, Calif.--(BUSINESS WIRE)--Oxygen Biotherapeutics, Inc. (OTCBB:OXBO) today announced the appointment of Charles H. Seeman as the company’s chief financial officer and executive vice president finance and administration.
People
Tenax Therapeutics
MORE ON THIS TOPIC
Illustration showing finger pointing people to leave
Layoffs
Vedanta ‘Significantly’ Reduces Staff, Focuses on Phase III Study of C. Diff Drug
January 16, 2026
 · 
2 min read
 · 
Angela Gabriel
Vector of a businessman standing at cross his career being offered financial incentives
Business
JPM26: Protagonist Has a $400M Decision To Make. It’s a No-Brainer
January 16, 2026
 · 
2 min read
 · 
Annalee Armstrong
Contemporary art collage of human hands holding a arrow pointing up, graphs and diagrams. Concept of profit, making money, business. Copy space.
Mergers & acquisitions
Speculation of Sanofi Takeover Sends Ocular’s Stock Soaring
January 16, 2026
 · 
1 min read
 · 
Tristan Manalac
Fund raising Capital Donation. Funds Support Concept. Fundraising. Collecting donations in jar.
Funding
Novo Foundation Pumps $850M Into Denmark, Europe to Bolster Innovation
January 16, 2026
 · 
2 min read
 · 
Tristan Manalac